Around January 29, 2020, Janssen Pharmaceutical Companies, led by Hanneke Schuitemaker, announced that they had started work on the development of a vaccine.
Tarehe 29, Januari 2020, Janssen Pharmaceutical Companies, wakiongozwa na Hanneke Schuitemaker, walitangaza kuwa walianza kushughulikia kutengeneza chanjo.